Inogen, Inc. Quarterly report pursuant to Section 13 or 15(d)

Quarterly report pursuant to Section 13 or 15(d)

Stockholders' Equity (Tables)

Stockholders' Equity (Tables)

3 Months Ended

Mar. 31, 2020

The activity for stock options under the Company’s stock plans for the three months ended March 31, 2020 is as follows:

								Remaining
								weighted-
						Weighted-		average		Per share
						average		contractual		average
				Price per		exercise		terms		intrinsic
	Options			share		price		(in years)		value
Outstanding as of December 31, 2019		980,884		$0.75-$83.30		$	35.24		2.84	$	34.07
Granted		—			—		—
Exercised		(6,334	)	1.17-24.52			9.42
Forfeited		(1,876	)	44.19-56.72			52.54
Expired		—			—		—
Outstanding as of March 31, 2020		972,674		0.75-83.30			35.38		2.59		18.39
Vested and exercisable as of March 31, 2020		953,431		0.75-83.30			35.20		2.58		18.61
Vested and expected to vest as of March 31, 2020		971,431		$0.75-$83.30		$	35.37		2.59	$	18.40

Summary of Restricted Stock Activity

Stock Awards activity for the three months ended March 31, 2020 is summarized below:

										Weighted-
										average
										grant
				Performance						date fair
				and						value
Restricted stock units	Time-based			time-based			Total			per share
Unvested restricted stock units as of December 31, 2019		108,976			3,134			112,110		$	83.48
Granted		145,413			58,972			204,385			45.78
Vested		(10,309	)		—			(10,309	)		107.85
Forfeited/canceled		(4,293	)		(3,134	)		(7,427	)		100.06
Unvested restricted stock units as of March 31, 2020 ⁽¹⁾		239,787			58,972			298,759		$	56.44
Unvested and expected to vest restricted stock units outstanding as of March 31, 2020								263,337		$	57.23

										Weighted-
										average
										grant
				Performance						date fair
				and						value
Restricted stock awards	Time-based			time-based			Total			per share
Unvested restricted stock awards outstanding as of December 31, 2019		71,070			62,628			133,698		$	95.74
Granted		—			—			—			—
Vested		(8,301	)		—			(8,301	)		108.51
Forfeited/canceled		—			(29,273	)		(29,273	)		110.27
Unvested restricted stock awards outstanding as of March 31, 2020 ⁽¹⁾		62,769			33,355			96,124		$	90.97
Unvested and expected to vest restricted stock awards outstanding as of March 31, 2020								76,815		$	90.08

(1)	Outstanding restricted stock units and restricted stock awards are based on the maximum payout of the targeted number of shares.

Summary of Stock-based Compensation Expense

Stock-based compensation

Stock-based compensation expense recognized for the three months ended March 31, 2020 and March 31, 2019, was as follows:

	Three months ended
	March 31,
	2020		2019
Stock-based compensation expense by type of award:
Stock option plan awards	$	525	$	1,147
Restricted stock units and restricted stock awards		2,083		2,257
Employee stock purchase plan		176		182
Total stock-based compensation expense	$	2,784	$	3,586

For the three months ended March 31, 2020 and March 31, 2019, respectively, stock-based compensation expense recognized under ASC 718, included in cost of revenue, research and development expense, sales and marketing expense, and general and administrative expense was as follows:

	Three months ended
	March 31,
	2020		2019
Cost of revenue	$	229	$	285
Research and development		320		377
Sales and marketing		612		690
General and administrative		1,623		2,234
Total stock-based compensation expense	$	2,784	$	3,586